Literature DB >> 29180554

Frequency of Cannabis Use Among Primary Care Patients in Washington State.

Gwen T Lapham1, Amy K Lee2, Ryan M Caldeiro2, Dennis McCarty2, Kendall C Browne2, Denise D Walker2, Daniel R Kivlahan2, Katharine A Bradley2.   

Abstract

INTRODUCTION: Over 12% of US adults report past-year cannabis use, and among those who use daily, 25% or more have a cannabis use disorder. Use is increasing as legal access expands. Yet, cannabis use is not routinely assessed in primary care, and little is known about use among primary care patients and relevant demographic and behavioral health subgroups. This study describes the prevalence and frequency of past-year cannabis use among primary care patients assessed for use during a primary care visit.
METHODS: This observational cohort study included adults who made a visit to primary care clinics with annual behavioral health screening, including a single-item question about frequency past-year cannabis use (March 2015 to February 2016; n = 29,857). Depression, alcohol and other drug use were also assessed by behavioral health screening. Screening results, tobacco use, and diagnoses for past-year behavioral health conditions (e.g., mental health and substance use disorders) were obtained from EHRs.
RESULTS: Among patients who completed the cannabis use question (n = 22,095; 74% of eligible patients), 15.3% (14.8% to 15.8%) reported any past-year use: 12.2% (11.8% to 12.6%) less than daily, and 3.1% (2.9%-3.3%) daily. Among 2228 patients age 18 to 29 years, 36.0% (34.0% to 38.0%) reported any cannabis use and 8.1% (7.0% to 9.3%) daily use. Daily cannabis use was common among men age 18 to 29 years who used tobacco or screened positive for depression or used tobacco: 25.5% (18.8% to 32.1%) and 31.7% (23.3% to 40.0%), respectively.
CONCLUSIONS: Cannabis use was common in adult primary care patients, especially among younger patients and those with behavioral health conditions. Results highlight the need for primary care approaches to address cannabis use. © Copyright 2017 by the American Board of Family Medicine.

Entities:  

Keywords:  Cannabis; Primary Health Care; Screening; Washington

Mesh:

Year:  2017        PMID: 29180554      PMCID: PMC5769869          DOI: 10.3122/jabfm.2017.06.170062

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  43 in total

Review 1.  In the weeds: a baseline view of cannabis use among legalizing states and their neighbours.

Authors:  Rosalie Liccardo Pacula; Mireille Jacobson; Ervant J Maksabedian
Journal:  Addiction       Date:  2016-01-26       Impact factor: 6.526

2.  Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products.

Authors:  Ryan Vandrey; Jeffrey C Raber; Mark E Raber; Brad Douglass; Cameron Miller; Marcel O Bonn-Miller
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

3.  Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health.

Authors:  Brett C Haberstick; Susan E Young; Joanna S Zeiger; Jeffrey M Lessem; John K Hewitt; Christian J Hopfer
Journal:  Drug Alcohol Depend       Date:  2013-12-14       Impact factor: 4.492

Review 4.  Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Authors:  Kevin P Hill
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 5.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

6.  A new method of cannabis ingestion: the dangers of dabs?

Authors:  Mallory Loflin; Mitch Earleywine
Journal:  Addict Behav       Date:  2014-05-28       Impact factor: 3.913

Review 7.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

8.  Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.

Authors:  Carlos Blanco; Deborah S Hasin; Melanie M Wall; Ludwing Flórez-Salamanca; Nicolas Hoertel; Shuai Wang; Bradley T Kerridge; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

9.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

Review 10.  Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.

Authors:  J K L Gunn; C B Rosales; K E Center; A Nuñez; S J Gibson; C Christ; J E Ehiri
Journal:  BMJ Open       Date:  2016-04-05       Impact factor: 2.692

View more
  21 in total

1.  Prevalence of Behavioral Health Conditions Across Frequency of Cannabis Use Among Adult Primary Care Patients in Washington State.

Authors:  Gwen T Lapham; Amy K Lee; Ryan M Caldeiro; Joseph E Glass; David S Carrell; Julie E Richards; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2018-11       Impact factor: 5.128

2.  If You Listen, I Will Talk: the Experience of Being Asked About Suicidality During Routine Primary Care.

Authors:  Julie E Richards; Sarah D Hohl; Ursula Whiteside; Evette J Ludman; David C Grossman; Greg E Simon; Susan M Shortreed; Amy K Lee; Rebecca Parrish; Mary Shea; Ryan M Caldeiro; Robert B Penfold; Emily C Williams
Journal:  J Gen Intern Med       Date:  2019-07-25       Impact factor: 5.128

3.  The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.

Authors:  Gwen T Lapham; Cynthia I Campbell; Bobbi Jo H Yarborough; Rulin C Hechter; Brian K Ahmedani; Irina V Haller; Andrea H Kline-Simon; Derek D Satre; Amy M Loree; Constance Weisner; Ingrid A Binswanger
Journal:  Subst Abus       Date:  2019-01-18       Impact factor: 3.716

4.  Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: An evaluation in three pilot sites.

Authors:  Julie E Richards; Jennifer F Bobb; Amy K Lee; Gwen T Lapham; Emily C Williams; Joseph E Glass; Evette J Ludman; Carol Achtmeyer; Ryan M Caldeiro; Malia Oliver; Katharine A Bradley
Journal:  Drug Alcohol Depend       Date:  2019-06-08       Impact factor: 4.492

5.  Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system.

Authors:  Kai Yeung; Julie Richards; Eric Goemer; Paula Lozano; Gwen Lapham; Emily Williams; Joseph Glass; Amy Lee; Carol Achtmeyer; Ryan Caldeiro; Rebecca Parrish; Katharine Bradley
Journal:  Health Serv Res       Date:  2020-12       Impact factor: 3.402

6.  Cannabis use, other drug use, and risk of subsequent acute care in primary care patients.

Authors:  Theresa E Matson; Gwen T Lapham; Jennifer F Bobb; Eric Johnson; Julie E Richards; Amy K Lee; Katharine A Bradley; Joseph E Glass
Journal:  Drug Alcohol Depend       Date:  2020-08-08       Impact factor: 4.492

7.  Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.

Authors:  Mikko Sayre; Gwen T Lapham; Amy K Lee; Malia Oliver; Jennifer F Bobb; Ryan M Caldeiro; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2020-01-23       Impact factor: 5.128

8.  Tobacco quitline engagement and outcomes among primary care patients reporting use of tobacco or dual tobacco and cannabis: An observational study.

Authors:  Jennifer B McClure; Gwen Lapham
Journal:  Subst Abus       Date:  2020-12-03       Impact factor: 3.716

9.  Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.

Authors:  Jennifer McNeely; Angéline Adam; John Rotrosen; Sarah E Wakeman; Timothy E Wilens; Joseph Kannry; Richard N Rosenthal; Aimee Wahle; Seth Pitts; Sarah Farkas; Carmen Rosa; Lauren Peccoralo; Eva Waite; Aida Vega; Jennifer Kent; Catherine K Craven; Tamar A Kaminski; Elizabeth Firmin; Benjamin Isenberg; Melanie Harris; Andre Kushniruk; Leah Hamilton
Journal:  JAMA Netw Open       Date:  2021-05-03

10.  Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.

Authors:  Theresa E Matson; David S Carrell; Jennifer F Bobb; David J Cronkite; Malia M Oliver; Casey Luce; Udi E Ghitza; Clarissa W Hsu; Cynthia I Campbell; Kendall C Browne; Ingrid A Binswanger; Andrew J Saxon; Katharine A Bradley; Gwen T Lapham
Journal:  JAMA Netw Open       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.